BD PANEL PHOENIX NMIC-311
Report
- Report Number
- 1119779-2023-01176
- Event Type
- Malfunction
- Date Received
- October 25, 2023
- Date of Event
- September 15, 2023
- Report Date
- March 25, 2024
- Manufacturer
- BECTON, DICKINSON & CO. (SPARKS)
- Product Code
- LON
- UDI-DI
- 00382904494520
- PMA / PMN Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
H.3. A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.
H.6. INVESTIGATION SUMMARY: THIS COMPLAINT IS FOR FALSE POSITIVE ESBL RESULTS WITH ESCHERICHIA COLI WHEN USING PHOENIX PANEL NMIC-311 (CATALOG NUMBER 449452) BATCH NUMBER 3192080. THE CUSTOMER DID NOT PROVIDE PANEL RETURNS BUT PROVIDED ISOLATE RETURNS AND PHOENIX GENERATED LAB REPORTS FOR THE INVESTIGATION. THE LAB REPORTS SHOW POSITIVE ESBL RESULTS FOR E. COLI FROM A URINE SAMPLE AND BLOOD SAMPLE WHEN USING THE COMPLAINT BATCH. TO INVESTIGATE, THREE RETENTION PANELS EACH FROM COMPLAINT BATCH 3192080 WERE INOCULATED WITH CUSTOMER RETURNED ISOLATES E. COLI (BLD) AND E. COLI (URI) AND PLACED IN A PHOENIX M50 TO OBSERVE FOR ESBL RESULTS. ADDITIONALLY, TWO CONTROL PANELS EACH FROM THE SAME MATERIAL BUT DIFFERENT BATCH WERE INOCULATED CUSTOMER RETURNED ISOLATES E. COLI (BLD) AND E. COLI (URI) AND PLACED IN A PHOENIX M50 TO OBSERVE FOR ESBL RESULTS. DURING THE INVESTIGATION TESTING, TWO OF THE TEN PANELS TESTED CLASSIFIED THE ISOLATES AS ESBL NEGATIVE. THE OTHER EIGHT PANELS RETURNED ESBL POSITIVE OR ATYPICAL ESBL RESULTS. REVIEW OF THE BD TESTING LAB REPORTS, SHOWS THAT CAZ WAS RESISTANT. WHEN ONE OR MORE 3RD/4TH GENERATION CEPHALOSPORINS IS RESISTANT IT WILL REPORT AS AN ATYPICAL ESBL, TRIGGERING RULE 1437. RULE 1437 WAS PUT IN PLACE IN THE BDXPERT SYSTEM TO ALERT THE CUSTOMER TO PERFORM CONFIRMATORY TESTING. FOR FURTHER INVESTIGATION, ESBL CONFIRMATORY TESTING WAS PERFORMED WITH CUSTOMER RETURNED ISOLATE E. COLI (BLD) AS E. COLI (URI) WAS NOT VIABLE AT THE TIME OF ESBL CONFIRMATORY TESTING. A DIFFUSION DISC OF CEFTAZIDIME AND CEFTAZIDIME/CLAVULANIC ACID WERE PLACED ON A MUELLER-HINTON AGAR PLATE INOCULATED WITH E. COLI (BLD) TO OBSERVE FOR ESBL RESULTS. THE INVESTIGATION SHOWED NO DIFFERENCE IN THE INHIBITION ZONE OF THE TWO DISCS, CONFIRMING ESBL NEGATIVE RESULTS FOR E. COLI (BLD) BASED ON THE RESULTS OF THE INVESTIGATION, THIS COMPLAINT IS CONFIRMED FOR FALSE POSITIVE ESBL RESULTS. THE BATCH HISTORY RECORDS WERE SATISFACTORY AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. COMPLAINT TRENDING WAS PERFORMED AND NO TRENDS WERE IDENTIFIED ASSOCIATED WITH THIS DEFECT. A REVIEW OF COMPLAINTS REVEALED NO OTHER COMPLAINTS ON THIS BATCH. BD ID/AST PLANT QUALITY WILL CONTINUE TO MONITOR FOR TRENDS AND TAKE ACTION AS NECESSARY.
IT WAS REPORTED THAT WHILE USING BD PANEL PHOENIX NMIC-311 THAT THERE WAS ONE FASLE POSITVE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER HAS AN ORGANISM TESTING AS FALSE POSITIVE ESBL. PATIENT HAS E. COLI ISOLATED FROM BOTH URINE AND BLOOD. URINE ISOLATE TESTED AS ESBL, BLOOD DID NOT. ORGANISMS WERE SENT TO REFERENCE LAB FOR ALTERNATE METHOD OF TESTING FOR ESBL. THE ORGANISMS TESTED NEGATIVE FOR ESBL ON THE REFERENCE LAB'S MICROSCAN INSTRUMENT. FALSE POSITIVE ESBL.
IT WAS REPORTED THAT WHILE USING BD PANEL PHOENIX NMIC-311 THAT THERE WAS ONE "FALSE" "POSITIVE". THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: CUSTOMER HAS AN ORGANISM TESTING AS FALSE POSITIVE ESBL. PATIENT HAS E. COLI ISOLATED FROM BOTH URINE AND BLOOD. URINE ISOLATE TESTED AS ESBL, BLOOD DID NOT. ORGANISMS WERE SENT TO REFERENCE LAB FOR ALTERNATE METHOD OF TESTING FOR ESBL. THE ORGANISMS TESTED NEGATIVE FOR ESBL ON THE REFERENCE LAB'S MICROSCAN INSTRUMENT. FALSE POSITIVE ESBL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1047729 | BD PANEL PHOENIX NMIC-311 | SYSTEM, TEST, AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY | LON | BECTON, DICKINSON & CO. (SPARKS) | 3192080 | 00382904494520 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown |